Market Overview:
The global male infertility treatment market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into DNA fragmentation technique, oxidative stress analysis, microscopic examination, sperm agglutination, computer assisted semen analysis (CASA), sperm penetration assay (SPA), and others. The DNA fragmentation technique segment is expected to grow at a CAGR of 6.1% during the forecast period from 2018 to 2030 owing to increasing awareness about this technique among males for infertility diagnosis. On the basis of application, hospitals are expected to hold a major share in the global male infertility treatment market in 2018 owing to increasing number of patients seeking for diagnosis and treatment for male infertility in hospitals across regions worldwide.
Product Definition:
Male infertility treatment is a way to help men who are unable to conceive a child naturally because they have problems with their sperm. Treatment may involve surgery to correct a problem with the sperm, medicine to improve sperm quality or assisted reproductive technologies (ART) such as in vitro fertilization. Treatment for male infertility is important because it can allow couples who want children to conceive them naturally.
DNA Fragmentation Technique:
The global DNA fragmentation technique market size was valued at USD 1.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The rising prevalence of male infertility across the globe is one of the key growth drivers for this vertical as it is one of the major causes leading to reduced sperm count and motility.
Oxidative Stress Analysis:
Oxidative stress analysis is a technique used for determining the level of oxidative damage in various tissues and organs of the body. Oxidative stress analysis in male infertility treatment market is used to evaluate if there are any damages or abnormalities in sperm DNA, chromatin structure, and other factors that may cause infertility.
Application Insights:
The others segment held the largest share of over 60.0% in 2017. The application includes mail order and other non-clinical methods for male infertility treatment such as adoption, artificial insemination and donor sperm. Artificial insemination is a well-established method for treating male infertility; however, it is more commonly used for cattle breeding than humans.
Male factor contributes to around 30% of cases where female partner suffers from fertility problems due to low sperm count or quality (azoospermia). Sperm penetration assay is one of the popular methods used by clinicians at times when assisted reproductive technology (ART) cannot be employed because of religious prohibitions against ART procedures or if there are no suitable donors available within a reasonable travel distance from the couple¢â‚¬â„¢s home location.
Regional Analysis:
North America dominated the global male infertility treatment market in 2017. This can be attributed to rising awareness about available treatments, high cost of procedures in this region and increasing government support for R&D activities. For instance, as per a research paper published by American Urological Association in 2016, there was a 41% increase in the number of men undergoing IVF procedures from 2005 to 2014. In addition, presence of well-established healthcare facilities and availability of advanced treatment options are also driving growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rise in aging population and prevalence of various chronic diseases such as diabetes which leads to reduced fertility rates among men resulting into shortage of mates which will boost demand for MTT techniques over next eight years (2018 To 2030). Moreover, growing medical tourism industry due low costs compared with western countries will drive demand further contributing towards revenue generation during same period (8th decade).
Growth Factors:
- Increasing awareness about male infertility and its treatment options among people.
- Growing incidence of male infertility due to changing lifestyle and environmental factors.
- Rising demand for assisted reproductive technologies (ART) for treating male infertility.
- Availability of advanced and innovative Male Infertility Treatment procedures and products.
- increasing affordability of Male Infertility Treatment procedures and products
Scope Of The Report
Report Attributes
Report Details
Report Title
Male Infertility Treatment Market Research Report
By Type
DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay, Others
By Application
Hospitals, Clinics, Others
By Companies
EMD Sereno, Aytu BioScience, Bayer, Cadila, Intas Pharma, Halotech DNA, SCSA diagnostics, Andrology Solutions
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Male Infertility Treatment Market Report Segments:
The global Male Infertility Treatment market is segmented on the basis of:
Types
DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- EMD Sereno
- Aytu BioScience
- Bayer
- Cadila
- Intas Pharma
- Halotech DNA
- SCSA diagnostics
- Andrology Solutions
Highlights of The Male Infertility Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA Fragmentation Technique
- Oxidative Stress Analysis
- Microscopic Examination
- Sperm Agglutination
- Computer Assisted Semen Analysis
- Sperm Penetration Assay
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Male Infertility Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Male infertility treatment is a process that is used to treat male infertility. Male infertility can be caused by problems with the sperm or the testicles. Treatment for male infertility may involve surgery, medications, or a combination of both.
Some of the major companies in the male infertility treatment market are EMD Sereno, Aytu BioScience, Bayer, Cadila, Intas Pharma, Halotech DNA, SCSA diagnostics, Andrology Solutions.
The male infertility treatment market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Male Infertility Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Male Infertility Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Male Infertility Treatment Market - Supply Chain
4.5. Global Male Infertility Treatment Market Forecast
4.5.1. Male Infertility Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Male Infertility Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Male Infertility Treatment Market Absolute $ Opportunity
5. Global Male Infertility Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Male Infertility Treatment Market Size and Volume Forecast by Type
5.3.1. DNA Fragmentation Technique
5.3.2. Oxidative Stress Analysis
5.3.3. Microscopic Examination
5.3.4. Sperm Agglutination
5.3.5. Computer Assisted Semen Analysis
5.3.6. Sperm Penetration Assay
5.3.7. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Male Infertility Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Male Infertility Treatment Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Male Infertility Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Male Infertility Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Male Infertility Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Male Infertility Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Male Infertility Treatment Demand Share Forecast, 2019-2026
9. North America Male Infertility Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Male Infertility Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Male Infertility Treatment Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Male Infertility Treatment Market Size and Volume Forecast by Type
9.7.1. DNA Fragmentation Technique
9.7.2. Oxidative Stress Analysis
9.7.3. Microscopic Examination
9.7.4. Sperm Agglutination
9.7.5. Computer Assisted Semen Analysis
9.7.6. Sperm Penetration Assay
9.7.7. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Male Infertility Treatment Demand Share Forecast, 2019-2026
10. Latin America Male Infertility Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Male Infertility Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Male Infertility Treatment Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Male Infertility Treatment Market Size and Volume Forecast by Type
10.7.1. DNA Fragmentation Technique
10.7.2. Oxidative Stress Analysis
10.7.3. Microscopic Examination
10.7.4. Sperm Agglutination
10.7.5. Computer Assisted Semen Analysis
10.7.6. Sperm Penetration Assay
10.7.7. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Male Infertility Treatment Demand Share Forecast, 2019-2026
11. Europe Male Infertility Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Male Infertility Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Male Infertility Treatment Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Male Infertility Treatment Market Size and Volume Forecast by Type
11.7.1. DNA Fragmentation Technique
11.7.2. Oxidative Stress Analysis
11.7.3. Microscopic Examination
1.7.4. Sperm Agglutination
11.7.5. Computer Assisted Semen Analysis
11.7.6. Sperm Penetration Assay
11.7.7. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Male Infertility Treatment Demand Share, 2019-2026
12. Asia Pacific Male Infertility Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Male Infertility Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Male Infertility Treatment Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Male Infertility Treatment Market Size and Volume Forecast by Type
12.7.1. DNA Fragmentation Technique
12.7.2. Oxidative Stress Analysis
12.7.3. Microscopic Examination
12.7.4. Sperm Agglutination
12.7.5. Computer Assisted Semen Analysis
12.7.6. Sperm Penetration Assay
12.7.7. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Male Infertility Treatment Demand Share, 2019-2026
13. Middle East & Africa Male Infertility Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Male Infertility Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Male Infertility Treatment Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Male Infertility Treatment Market Size and Volume Forecast by Type
13.7.1. DNA Fragmentation Technique
13.7.2. Oxidative Stress Analysis
13.7.3. Microscopic Examination
13.7.4. Sperm Agglutination
13.7.5. Computer Assisted Semen Analysis
13.7.6. Sperm Penetration Assay
13.7.7. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Male Infertility Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Male Infertility Treatment Market: Market Share Analysis
14.2. Male Infertility Treatment Distributors and Customers
14.3. Male Infertility Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. EMD Sereno
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Aytu BioScience
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bayer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cadila
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Intas Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Halotech DNA
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. SCSA diagnostics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Andrology Solutions
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
